Annual Drug Patent Expirations for OSPHENA
Osphena is a drug marketed by Duchesnay and is included in one NDA. It is available from two suppliers. There are seven patents protecting this drug.
Drug patent litigation for OSPHENA.
This drug has eigthy-three patent family members in thirty-one countries.
The generic ingredient in OSPHENA is ospemifene. Two suppliers are listed for this compound. Additional details are available on the ospemifene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
